Trial intelligence / Profile preview

Subtenon Block in Vitreoretinal Surgery

NCT02282774Phase 3Completed

Sponsor
King Saud University
Start
Dec 2013
Primary completion
Jun 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of lidocaine and bupivacaine in postoperative pain (2 arms), sponsored by King Saud University. Primary endpoint: Time to first postoperative analgesic dose at 24 hours. Started Dec 2013; status: completed.

02

Drugs

lidocainebupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02282774.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02282774.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call